American Portfolios Advisors’s La Jolla Pharmaceutical Company LJPC Stock Holding History

American Portfolios Advisors’s Portfolio LJPC Stock Details LJPC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,000	Closed	-$4.27K	–	3679
2022 Q1	$4.27K	Hold	1,000	–	–	﹤0.01%	2997
2021 Q4	$4.65K	Sell	1,000 -500	-33%	-$2.08K	﹤0.01%	2921
2021 Q3	$5.99K	Hold	1,500	–	–	﹤0.01%	2777
2021 Q2	$6.42K	Hold	1,500	–	–	﹤0.01%	2718
2021 Q1	$6.36K	Hold	1,500	–	–	﹤0.01%	2602
2020 Q4	$5.82K	Sell	1,500 -1,400	-48%	-$5.98K	﹤0.01%	2349
2020 Q3	$11.7K	Sell	2,900 -1,200	-29%	-$4.97K	﹤0.01%	1920
2020 Q2	$17.5K	Buy	+4,100	New	+$25K	﹤0.01%	1698

Other funds holding LJPC

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Kevin Tang $783 AUM 75.59% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

American Portfolios Advisors's LJPC Position: Q2 2022 in Review

American Portfolios Advisors sold out of La Jolla Pharmaceutical Company (LJPC) in Q2 2022, closing a stake of 1,000 shares — an estimated $4.27K sold.

American Portfolios Advisors first reported a position in LJPC in Q2 2020 and held it in 8 quarters. The position peaked at $17.5K in Q2 2020. 41 funds tracked by Wall St. Rank hold LJPC as of Q2 2022.

American Portfolios Advisors reported no remaining La Jolla Pharmaceutical Company position as of Q2 2022 after selling out during the quarter.
American Portfolios Advisors sold 1,000 La Jolla Pharmaceutical Company shares in Q2 2022, an estimated $4.27K.
American Portfolios Advisors first reported a position in La Jolla Pharmaceutical Company in Q2 2020 and held it in 8 quarters.
American Portfolios Advisors's La Jolla Pharmaceutical Company position peaked at $17.5K in Q2 2020.
41 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q2 2022.

Based on American Portfolios Advisors's 13F filing for Q2 2022, filed 20 Mar 2023.